Asia Pacific Artificial Intelligence In Drug Discovery Market Size & Outlook

The artificial intelligence in drug discovery market in Asia Pacific is expected to reach a projected revenue of US$ 2,165.2 million by 2030. A compound annual growth rate of 32.4% is expected of Asia Pacific artificial intelligence in drug discovery market from 2024 to 2030.
Revenue, 2023 (US$M)
$303.2
Forecast, 2030 (US$M)
$2,165.2
CAGR, 2024 - 2030
32.4%
Report Coverage
Asia Pacific

Asia Pacific artificial intelligence in drug discovery market, 2018-2030 (US$M)

Asia

Related Markets

Asia Pacific artificial intelligence in drug discovery market highlights

  • The Asia Pacific artificial intelligence in drug discovery market generated a revenue of USD 303.2 million in 2023.
  • The market is expected to grow at a CAGR of 32.4% from 2024 to 2030.
  • In terms of segment, drug optimization & repurposing was the largest revenue generating application in 2023.
  • Drug Optimization & Repurposing is the most lucrative application segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2024 to 2030.


Asia Pacific data book summary

Market revenue in 2023USD 303.2 million
Market revenue in 2030USD 2,165.2 million
Growth rate32.4% (CAGR from 2023 to 2030)
Largest segmentDrug optimization & repurposing
Fastest growing segmentDrug Optimization & Repurposing
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDrug Optimization & Repurposing, Preclinical Testing
Key market players worldwideInternational Business Machines Corp, Exscientia PLC ADR, Alphabet Inc Class A, Benevolent AI, Recursion Pharmaceuticals Inc Class A, Aitia, BioSymetrics, Euretos, Berg, Atomwise, Insitro


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 20.3% of the global artificial intelligence in drug discovery market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 2,165.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Artificial Intelligence In Drug Discovery Market Scope

Artificial intelligence in drug discovery market segmentation & scope
Consumer Electronics
Healthcare
Automotive
Military & Defense
Media & Entertainment
Drug Discovery & Development
Precision Medicine
Diagnotics
Others
Orthopedics
Neurology
Urology
Gynecology
Processor
Connectivity IC
Sensors

Artificial Intelligence In Drug Discovery Market Companies

Name Profile # Employees HQ Website

Asia Pacific artificial intelligence in drug discovery market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in drug discovery market will help companies and investors design strategic landscapes.


Drug optimization & repurposing was the largest segment with a revenue share of 53.73% in 2023. Horizon Databook has segmented the Asia Pacific artificial intelligence in drug discovery market based on drug optimization & repurposing, preclinical testing covering the revenue growth of each sub-segment from 2018 to 2030.


Increasing patient pool, growing acceptance of cloud computing, and rising number of government programs supporting AI are primary factors expected to drive the market. In addition, increasing number of biopharmaceutical firms are applying AI to modernize the drug discovery process. 

AI application is found in the field of diagnostics. For instance, in 2017, China’s Tencent introduced an AI-driven diagnostic medical imaging facility, called AI Medical Innovation System (AIMIS). The technology exhibited 90% and 95% accuracy.

for initial diagnoses of esophageal & lung cancers, respectively. In April 2020, Cyclica announced a multiyear & multiproject collaboration with the Genome Institute of Singapore (GIS). The collaboration aims to carry out research efforts extending.

Reasons to subscribe to Asia Pacific artificial intelligence in drug discovery market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific artificial intelligence in drug discovery market databook

  • Our clientele includes a mix of artificial intelligence in drug discovery market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific artificial intelligence in drug discovery market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific artificial intelligence in drug discovery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific artificial intelligence in drug discovery market size, by country, 2018-2030 (US$M)

Asia Pacific Artificial Intelligence In Drug Discovery Market Outlook Share, 2023 & 2030 (US$M)

Asia Pacific artificial intelligence in drug discovery market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more